Abstract:
A system and method of guided video creation is described. In an exemplary method, the system guides a user to create a video production based on a set of pre-defined activities. In one embodiment, the system detects a selection of an item in a shotlist. In response to the item selection, the system stores structured metadata about the selection, opens the video camera and displays a dynamic video overlay relevant to the item selection. In addition, the system detects contact with an overlay button in the dynamic video overlay configured to toggle visibility of the dynamic video overlay. The system further receives a command to save a recorded clip of video content, stores additional metadata for the recorded clip of the video content, and updates the respective item in the shotlist.
Abstract:
A system and method of guided video creation is described. In an exemplary method, the system guides a user to create a video production based on a set of pre-defined activities. In one embodiment, the system detects a selection of an item in a shotlist. In response to the item selection, the system stores structured metadata about the selection, opens the video camera and displays a dynamic video overlay relevant to the item selection. In addition, the system detects contact with an overlay button in the dynamic video overlay configured to toggle visibility of the dynamic video overlay. The system further receives a command to save a recorded clip of video content, stores additional metadata for the recorded clip of the video content, and updates the respective item in the shotlist.
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:2所示的氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 8. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:8所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
Abstract:
The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
Abstract:
The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein derived from Fransicella tularensis comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
Abstract translation:本发明涉及病原菌的新型药物靶标。 因此,本发明提供了从包含SEQ ID NO:2所示氨基酸序列的土拉氏弗斯兰氏菌得到的纯化蛋白质。本发明还提供了本发明多肽的生物化学和生物物理学特征。